A carregar cotações...
Previsão
| Comprar |
1 |
| Manter |
0 |
| Vender |
0 |
Notícias Ir para o feed de notícias
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Mais em de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Mais em de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Mais em de.investing.com
Dados financeiros da empresa
| (EUR) | setembro de 2025 | YoY |
|---|---|---|
| Receitas | 68,1 mi | - |
| Ganho bruto | 19,52 mi | - |
| Ganho líquido | -12,15 mi | - |
| EBITDA | 6,65 mi | - |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 12,92 mi |
Número de ações | 497,46 mi |
Máximo/mínimo de 52 semanas | € 0,14 - € 0,0178 |
| Dividendos | Não |
Beta | 1,05 |
PER (PE Ratio) | -0,15 |
PEG (PEG Ratio) | 0,00 |
P/VC (PB Ratio) | -0,10 |
P/V (PS Ratio) | 0,09 |
Perfil da empresa
The Cannabist Company Holdings Inc. dedica-se ao cultivo, fabrico e fornecimento de produtos e serviços relacionados com cannabis nos Estados Unidos e internacionalmente. A empresa oferece produtos que abrangem flores, comestíveis, óleos e comprimidos sob as marcas Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press e Amber. Detém licenças em 17 jurisdições nos Estados Unidos. A empresa era anteriormente conhecida como Columbia Care Inc. e mudou o seu nome para The Cannabist Company Holdings Inc. em setembro de 2023. A empresa foi fundada em 2012 e tem sede em Nova Iorque, Nova Iorque.
| Nome | Cannabist Co. Holdings Aktie |
| CEO | Christopher Marr |
| Sede | Malvern,
pa EUA |
| Site | |
| Entrada em bolsa | 29/04/2019 |
| Colaboradores | 2.829 |
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |